- NEGATIVE
Quarterly Revenue Insecticides Jun-2026 Quarterly Revenue is Rs 621 Cr which is growth of -10.6% YoY.
- NEGATIVE
Quarterly Net Profit Insecticides Jun-2026 Quarterly Net Profit is Rs 42 Cr which is growth of -27.0% YoY.
581.309.80(1.71%)
5,177
NSE+BSE Volume
NSE 09 Oct, 2026 3:31 PM (IST)
Insecticides quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents
Insecticides quarterly results: revenue, profit, and P&L – 13 quarter history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
| Indicator | Graph | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | Jun '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 621.1 | 432.8 | 384.5 | 643.9 | 695.1 | 362.1 | 359.4 | 628.8 | 659.2 | 277.1 | 359.2 | 695.8 | 643.8 | ||
Operating Exp. | 550.6 | 400.6 | 358.3 | 556.4 | 607.3 | 330.7 | 330.6 | 537.4 | 584.9 | 263.2 | 331.9 | 613.7 | 594.3 | |
Operating Profit | 65.9 | 27.4 | 25.3 | 84.9 | 84 | 28.5 | 28.7 | 89.9 | 71.8 | 9.3 | 26 | 82.3 | 45.7 | |
Operating Profit Margin % | 10.69% | 6.40% | 6.59% | 13.23% | 12.15% | 7.93% | 7.98% | 14.33% | 10.94% | 3.40% | 7.27% | 11.82% | 7.13% | |
Depr. | 9.6 | 9.3 | 9.3 | 9.3 | 7.3 | 7.1 | 7.6 | 7.2 | 7.1 | 7.6 | 7.4 | 7.4 | 6.9 | |
Interest | 4.7 | 4.2 | 4.6 | 4.1 | 3.7 | 2 | 1.4 | 1.7 | 1.6 | 2.1 | 2.8 | 2.9 | 3.2 | |
Profit Before Tax | 56.3 | 18.7 | 12.2 | 74.2 | 76.9 | 22.3 | 19.9 | 82.5 | 65.6 | 4.2 | 17 | 71.9 | 39.5 | |
Tax | 14.4 | 4.3 | 3.4 | 18.9 | 19.6 | 8.2 | 4.9 | 20.9 | 16.5 | -3.9 | 4.8 | 18.7 | 10.5 | |
Net Profit | 41.8 | 14.4 | 8.8 | 55.3 | 57.3 | 14 | 15 | 61.6 | 49.1 | 8.1 | 12.3 | 53.2 | 29 | |
EPS Adj. latest | 14.4 | 4.9 | 3 | 19 | 19.7 | 4.8 | 5.2 | 21.2 | 16.9 | 2.8 | 4.2 | 18.3 | 10 | |
Net profit TTM | 120.4 | 135.8 | 135.5 | 141.6 | 147.9 | 139.8 | 133.8 | 131.1 | 122.7 | 102.6 | 65.5 | 62.6 | 54 | |
Basic EPS TTM | 41.4 | 46.7 | 46.6 | 48.7 | 50.8 | 48 | 46 | 44.3 | 41.5 | 34.7 | 22.1 | 21.2 | 18.3 | |
Earnings Transcripts | ||||||||||||||
AI Summary | ||||||||||||||
Results PDF | ||||||||||||||
Result Notes |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Insecticides competitor comparison and performance snapshot within industry
Insecticides revenue mix: sales, profit, and capital employed breakups by segment
Insecticides annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Annual Revenue Insecticides Mar-2026 Annual Revenue is Rs 2,156 Cr which is growth of 7.3% YoY.
- NEGATIVE
Annual Net Profit Insecticides Mar-2026 Annual Net Profit is Rs 136 Cr which is growth of -2.8% YoY.
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
7.3%
2Y CAGR
4.5%
3Y CAGR
6.2%
5Y CAGR
8.6%
7Y CAGR
8.8%
10Y CAGR
8.1%
Total Revenue Annual growth is stable compared to historical averages.
Net Profit Ann.
1Y CHG
-2.9%
2Y CAGR
15%
3Y CAGR
29.2%
5Y CAGR
7.8%
7Y CAGR
1.5%
10Y CAGR
13.2%
Net Profit Annual is falling faster than historical averages.
Operating Exp. Ann.
1Y CHG
7.8%
2Y CAGR
3.3%
3Y CAGR
4.6%
5Y CAGR
8.7%
7Y CAGR
9.7%
10Y CAGR
7.9%
Operating Expenses Annual Cr growth is stable compared to historical averages.
Insecticides balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Total Shareholders Fund Insecticides Mar-2026 Total Shareholders Fund is Rs 1,214 Cr which is growth of 12.2% YoY.
- POSITIVE
Total Assets Insecticides Mar-2026 Total Assets is Rs 1,985 Cr which is growth of 5.2% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | Mar '16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9.9% | 8.2% | 1,214 | 1,081.8 | 1,011.1 | 915.7 | 867.2 | 818.4 | 730.2 | 661.4 | 547.6 | 464.6 | 408.9 | ||
Minority Interest Liability Ann. | - | - | - | - | - | - | - | - | - | - | - | - | - | |
28.4% | 13.2% | 39.2 | 36.4 | 43.8 | 18.5 | 18.8 | 21.1 | 23.4 | 19.9 | 27.7 | 24.9 | 52.5 | ||
-1.2% | 4.6% | 732.3 | 769.4 | 654.8 | 759.5 | 507.8 | 584.5 | 539.3 | 673.6 | 424.8 | 489 | 475.1 | ||
Total Capital Plus Liabilities Ann. | 5.4% | 6.9% | 1,985.4 | 1,887.6 | 1,709.8 | 1,693.7 | 1,393.8 | 1,424 | 1,292.9 | 1,354.9 | 1,000.1 | 978.4 | 936.5 | |
8.7% | 10.7% | 493.9 | 439.4 | 424.4 | 384.8 | 344 | 297.5 | 278.1 | 259.2 | 248.4 | 242.8 | 245.2 | ||
6.2% | 10.4% | 553.1 | 475.9 | 462.6 | 461.7 | 391.1 | 337.9 | 314.6 | 292.5 | 280.6 | 263.2 | 263.9 | ||
5.2% | 5.7% | 1,432.4 | 1,411.7 | 1,247.2 | 1,232 | 1,002.7 | 1,086.1 | 978.3 | 1,062.4 | 719.5 | 715.2 | 672.6 | ||
Total Assets Ann. | 5.4% | 6.9% | 1,985.4 | 1,887.6 | 1,709.8 | 1,693.7 | 1,393.8 | 1,424 | 1,292.9 | 1,354.9 | 1,000.1 | 978.4 | 936.5 | |
Contingent Liabilities plus Commitments Ann. | 15.7% | 10.5% | 161.6 | 167.6 | 109.8 | 104.3 | 225.1 | 97.9 | 93.4 | 74.9 | 91.4 | |||
Bonus Equity Share Capital Ann. | 0% | 17.6% | 17.8 | 17.8 | 17.8 | 17.8 | 7.9 | 7.9 | 7.9 | 7.9 | 7.9 | 7.9 | 7.9 | |
Non Current Investments Unquoted Book Value Ann. | - | - | 8 | 8 | ||||||||||
Current Investments Unquoted Book Value Ann. | - | - |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Total Assets Ann.
1Y CHG
5.2%
2Y CAGR
7.8%
3Y CAGR
5.4%
5Y CAGR
6.9%
7Y CAGR
5.6%
10Y CAGR
7.8%
Total Assets Annual growth is lower than historical averages.
Total Current Liabilities Ann.
1Y CHG
-4.8%
2Y CAGR
5.8%
3Y CAGR
-1.2%
5Y CAGR
4.6%
7Y CAGR
1.2%
10Y CAGR
4.4%
Total Current Liabilities Annual Cr is falling faster than historical averages.
Total ShareHolders Funds Ann.
1Y CHG
12.2%
2Y CAGR
9.6%
3Y CAGR
9.9%
5Y CAGR
8.2%
7Y CAGR
9.1%
10Y CAGR
11.5%
Total ShareHolders Funds Annual growth is higher than historical averages.
Insecticides ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Book Value Per Share Insecticides Mar-2026 Book Value Per Share is 417 Rs which is growth of 12.2% YoY.
- POSITIVE
ROE Insecticides Mar-2026 ROE is 11% which is growth of 1.7% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | Mar '16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BVSH Ann. | 10.5% | 1% | 417.2 | 371.8 | 341.6 | 309.4 | 439.5 | 396 | 353.3 | 320 | 265 | 224.8 | 197.8 | |
RoA Ann. % | 22.6% | 0.8% | 6.84% | 7.40% | 6.00% | 3.71% | 7.67% | 6.56% | 6.65% | 9.03% | 8.39% | 6.07% | 4.19% | |
ROE Ann. % | 17.6% | -0.4% | 11.18% | 12.91% | 10.14% | 6.87% | 12.34% | 11.41% | 11.78% | 18.50% | 15.33% | 12.78% | 9.60% | |
ROCE Ann. % | 15.1% | -0.4% | 15.83% | 17.61% | 13.59% | 10.38% | 16.65% | 16.12% | 17.82% | 24.69% | 23.29% | 20.88% | 16.41% | |
Total Debt to Total Equity Ann. | -20.6% | 0% | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.3 | 0.5 | 0.2 | 0.5 | 0.4 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
ROE Ann. %
1Y CHG
-13.4%
2Y CAGR
5%
3Y CAGR
17.6%
5Y CAGR
-0.4%
7Y CAGR
-6.9%
10Y CAGR
1.5%
ROE Annual % is falling faster than historical averages.
RoA Ann. %
1Y CHG
-7.6%
2Y CAGR
6.8%
3Y CAGR
22.6%
5Y CAGR
0.8%
7Y CAGR
-3.9%
10Y CAGR
5%
RoA Annual % is falling faster than historical averages.
Current Ratio Ann.
1Y CHG
11.1%
2Y CAGR
2.6%
3Y CAGR
7.7%
5Y CAGR
1%
7Y CAGR
3.2%
10Y CAGR
3.6%
Current Ratio Annual growth is higher than historical averages.
Insecticides cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Cash From Operating Activity Insecticides Mar-2026 Cash From Operating Activity is Rs 109 Cr which is growth of 14.9% YoY.
- POSITIVE
Net Cash Flow Insecticides Mar-2026 Net Cash Flow is Rs 32 Cr which is growth of 659.6% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | Mar '16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
- | -6.9% | 108.7 | 94.6 | 184.6 | -10.6 | 134.9 | 155.4 | 241.9 | -133.1 | 181.5 | 4 | 84.5 | ||
Cash from Investing Act. Ann. | - | - | -90.2 | -38.7 | -43.8 | -86.7 | 9.3 | -112.6 | -24.1 | -49 | -25.8 | -13.6 | -18.8 | |
Cash from Financing Act. Ann. | -45.1% | - | 13.2 | -61.6 | -98.1 | 79.7 | -114.6 | -104 | -159 | 171.5 | -143 | 9.4 | -62.9 | |
- | - | 31.7 | -5.7 | 42.7 | -17.6 | 29.5 | -61.3 | 58.8 | -10.6 | 12.7 | -0.3 | 2.9 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Cash from Operating Act. Ann.
1Y CHG
14.9%
2Y CAGR
-23.3%
5Y CAGR
-6.9%
10Y CAGR
2.6%
Cash from Operating Activity Annual growth is stable compared to historical averages.
Cash from Financing Act. Ann.
3Y CAGR
-45.1%
7Y CAGR
-30.7%
Cash from Financing Annual Activity growth is stable compared to historical averages.
